Adrenergics' Series A Round

Adrenergics raised a round of funding on June 15, 2015.

Adrenergics is developing novel therapeutics to treat dilated cardiomyopathy (DCM) in patients that do not respond to existing therapies. Dilated cardiomyopathy is a disease of the muscle of the heart…

Articles about Adrenergics' Series A Round: